131 related articles for article (PubMed ID: 11172675)
1. The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds.
Bradshaw TD; Stevens MF; Westwell AD
Curr Med Chem; 2001 Feb; 8(2):203-10. PubMed ID: 11172675
[TBL] [Abstract][Full Text] [Related]
2. Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles.
Kashiyama E; Hutchinson I; Chua MS; Stinson SF; Phillips LR; Kaur G; Sausville EA; Bradshaw TD; Westwell AD; Stevens MF
J Med Chem; 1999 Oct; 42(20):4172-84. PubMed ID: 10514287
[TBL] [Abstract][Full Text] [Related]
3. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.
Bradshaw TD; Westwell AD
Curr Med Chem; 2004 Apr; 11(8):1009-21. PubMed ID: 15078163
[TBL] [Abstract][Full Text] [Related]
4. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
Shi DF; Bradshaw TD; Wrigley S; McCall CJ; Lelieveld P; Fichtner I; Stevens MF
J Med Chem; 1996 Aug; 39(17):3375-84. PubMed ID: 8765521
[TBL] [Abstract][Full Text] [Related]
5. Antitumour benzothiazoles. Part 20: 3'-cyano and 3'-alkynyl-substituted 2-(4'-aminophenyl)benzothiazoles as new potent and selective analogues.
Hutchinson I; Bradshaw TD; Matthews CS; Stevens MF; Westwell AD
Bioorg Med Chem Lett; 2003 Feb; 13(3):471-4. PubMed ID: 12565953
[TBL] [Abstract][Full Text] [Related]
6. 2-(4-aminophenyl) benzothiazole: a potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines.
Dubey R; Shrivastava PK; Basniwal PK; Bhattacharya S; Moorthy NS
Mini Rev Med Chem; 2006 Jun; 6(6):633-7. PubMed ID: 16787373
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines.
Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF
Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193
[TBL] [Abstract][Full Text] [Related]
8. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.
Hutchinson I; Chua MS; Browne HL; Trapani V; Bradshaw TD; Westwell AD; Stevens MF
J Med Chem; 2001 Apr; 44(9):1446-55. PubMed ID: 11311068
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles.
Bradshaw TD; Chua MS; Browne HL; Trapani V; Sausville EA; Stevens MF
Br J Cancer; 2002 Apr; 86(8):1348-54. PubMed ID: 11953897
[TBL] [Abstract][Full Text] [Related]
10. 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.
Bradshaw TD; Wrigley S; Shi DF; Schultz RJ; Paull KD; Stevens MF
Br J Cancer; 1998 Mar; 77(5):745-52. PubMed ID: 9514053
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445).
Bradshaw TD; Chua MS; Orr S; Matthews CS; Stevens MF
Br J Cancer; 2000 Jul; 83(2):270-7. PubMed ID: 10901382
[TBL] [Abstract][Full Text] [Related]
12. Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives.
Shi DF; Bradshaw TD; Chua MS; Westwell AD; Stevens MF
Bioorg Med Chem Lett; 2001 Apr; 11(8):1093-5. PubMed ID: 11327598
[TBL] [Abstract][Full Text] [Related]
13. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.
Bradshaw TD; Bibby MC; Double JA; Fichtner I; Cooper PA; Alley MC; Donohue S; Stinson SF; Tomaszewjski JE; Sausville EA; Stevens MF
Mol Cancer Ther; 2002 Feb; 1(4):239-46. PubMed ID: 12467219
[TBL] [Abstract][Full Text] [Related]
15. Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs.
Hutchinson I; Jennings SA; Vishnuvajjala BR; Westwell AD; Stevens MF
J Med Chem; 2002 Jan; 45(3):744-7. PubMed ID: 11806726
[TBL] [Abstract][Full Text] [Related]
16. Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo.
Bradshaw TD; Shi DF; Schultz RJ; Paull KD; Kelland L; Wilson A; Garner C; Fiebig HH; Wrigley S; Stevens MF
Br J Cancer; 1998 Aug; 78(4):421-9. PubMed ID: 9716022
[TBL] [Abstract][Full Text] [Related]
17. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF
Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884
[TBL] [Abstract][Full Text] [Related]
18. Antitumour benzothiazoles. Part 10: the synthesis and antitumour activity of benzothiazole substituted quinol derivatives.
Wells G; Bradshaw TD; Diana P; Seaton A; Shi DF; Westwell AD; Stevens MF
Bioorg Med Chem Lett; 2000 Mar; 10(5):513-5. PubMed ID: 10743960
[TBL] [Abstract][Full Text] [Related]
19. Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.
Stone EL; Citossi F; Singh R; Kaur B; Gaskell M; Farmer PB; Monks A; Hose C; Stevens MF; Leong CO; Stocks M; Kellam B; Marlow M; Bradshaw TD
Bioorg Med Chem; 2015 Nov; 23(21):6891-9. PubMed ID: 26474663
[TBL] [Abstract][Full Text] [Related]
20. 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines.
Wells G; Berry JM; Bradshaw TD; Burger AM; Seaton A; Wang B; Westwell AD; Stevens MF
J Med Chem; 2003 Feb; 46(4):532-41. PubMed ID: 12570375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]